MET expression and amplification in patients with localized gastric cancer.

BACKGROUND MET, the receptor for hepatocyte growth factor, has been proposed as a therapeutic target in gastric cancer. This study assessed the incidence of MET expression and gene amplification in tumors of Western patients with gastric cancer. METHODS Tumor specimens from patients enrolled on a preoperative chemotherapy study (NCI 5700) were examined… CONTINUE READING